Abstract CT233: Phase 2 clinical study to evaluate the efficacy and safety of intratumoral BO-112 in combination with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

Iván Márquez‐Rodas, Marisol Quintero, Juana Oramás et al.|Cancer Research|2021

Cited by 2